Intensified and protective CD4+ T cell immunity in mice with anti–dendritic cell HIV gag fusion antibody vaccine
Current human immunodeficiency virus (HIV) vaccine approaches emphasize prime boost strategies comprising multiple doses of DNA vaccine and recombinant viral vectors. We are developing a protein-based approach that directly harnesses principles for generating T cell immunity. Vaccine is delivered to...
Main Authors: | Trumpfheller, Christine, Finke, Jennifer S., López, Carolina B., Moran, Thomas M., Moltedo, Bruno, Soares, Helena, Huang, Yaoxing, Schlesinger, Sarah J., Park, Chae Gyu, Nussenzweig, Michel C., Granelli-Piperno, Angela, Steinman, Ralph M. |
---|---|
Format: | Online |
Language: | English |
Published: |
The Rockefeller University Press
2006
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2118242/ |
Similar Items
-
DC-SIGN (CD209) Mediates Dengue Virus Infection of Human Dendritic Cells
by: Tassaneetrithep, Boonrat, et al.
Published: (2003) -
APOBEC3G/3F mediates intrinsic resistance of monocyte-derived dendritic cells to HIV-1 infection
by: Pion, Marjorie, et al.
Published: (2006) -
In vivo targeting of HIV gag to dendritic cells in combination with poly ICLC is safe and immunogenic in healthy volunteers
by: Caskey, M, et al.
Published: (2012) -
Strategy for Identifying Dendritic Cell-Processed CD4+ T Cell Epitopes from the HIV Gag p24 Protein
by: Bozzacco, Leonia, et al.
Published: (2012) -
In Vivo Targeting of Antigens to Maturing Dendritic Cells via the DEC-205 Receptor Improves T Cell Vaccination
by: Bonifaz, Laura C., et al.
Published: (2004)